Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Tear Substance Indicates Possible Nerve Damage in Diabetes Patients

By LabMedica International staff writers
Posted on 17 Jul 2017
Measurement of levels of substance P peptide in tears has been proposed as a method for determining possible nerve damage in individuals suffering from diabetes.

Substance P is a neuropeptide composed of a chain of 11 amino acid residues. More...
It is member of the tachykinin neuropeptide family and acts as a neurotransmitter and neuromodulator. Its receptor - the neurokinin type 1 - is distributed over cytoplasmic and nuclear membranes of many cell types (neurons, glia, endothelia of capillaries and lymphatics, fibroblasts, stem cells, white blood cells) in many tissues and organs.

Investigators at the University of New South Wales (Sydney, Australia) determined total protein content and substance P concentrations in tear samples obtained from 17 healthy control individuals and nine diabetes patients. Corneal nerve fiber density, an indication of diabetes-related damage to the peripheral nerves (peripheral neuropathy), was measured by confocal microscopy.

Results revealed that while there was no significant difference in total protein content between the groups, substance P concentrations were significantly higher in the tears of the control group compared to the diabetes patients. The diabetes patients also displayed significantly lower corneal nerve fiber density, indicating loss of corneal nerve fibers. Substance P levels were moderately correlated with the corneal nerve fiber density measurements.

First author Dr. Maria Markoulli, a lecturer in optometry and vision science at the University of New South Wales, said, "The positive correlation between substance P and corneal nerve density indicates that substance P may be a potential biomarker for corneal nerve health."

The study was published in the July 7, 2017, issue of the journal Optometry and Vision Science.

Related Links:
University of New South Wales


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.